The Securities and Exchange Commission has not necessarily reviewed the information in this filing and has not determined if it is accurate and complete.
The reader should not assume that the information is accurate and complete.

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 13F

FORM 13F INFORMATION TABLE

OMB APPROVAL
OMB Number: 3235-0006
Estimated average burden
hours per response: 23.8

COLUMN 1 COLUMN 2 COLUMN 3 COLUMN 4 COLUMN 5 COLUMN 6 COLUMN 7 COLUMN 8
VALUE SHRS OR SH/ PUT/ INVESTMENT OTHER VOTING AUTHORITY
NAME OF ISSUER TITLE OF CLASS CUSIP FIGI (to the nearest dollar) PRN AMT PRN CALL DISCRETION MANAGER SOLE SHARED NONE
ARRIVENT BIOPHARMA INC COM 04272N102   27,578,802 1,494,786 SH   DFND   1,494,786 0 0
CIRCLE INTERNET GROUP INC COM CL A 172573107   2,519,158,016 19,001,041 SH   DFND   19,001,041 0 0
FIGMA INC CLASS A COM STK 316841105   45,499,015 877,174 SH   DFND   877,174 0 0
FRACTYL HEALTH INC COM 35168W103   7,765,867 4,884,193 SH   DFND   4,884,193 0 0
GITLAB INC CLASS A COM 37637K108   41,536,937 921,405 SH   DFND   921,405 0 0
MAPLEBEAR INC COM 565394103   26,125,736 710,711 SH   DFND   710,711 0 0
MAZE THERAPEUTICS INC COM 578784100   26,861,146 1,035,910 SH   DFND   1,035,910 0 0
SAMSARA INC COM CL A 79589L106   344,595,280 9,250,880 SH   DFND   9,250,880 0 0